Veterans Affairs Medical Center, Washington, DC; George Washington University, Washington, DC; Uniformed Services University, Washington, DC.
Veterans Affairs Medical Center, Washington, DC; Georgetown University, Washington, DC; MedStar Washington Hospital Center, Washington, DC.
Am J Med. 2021 Apr;134(4):e252-e263. doi: 10.1016/j.amjmed.2020.08.030. Epub 2020 Sep 30.
New hypertension and heart failure guidelines recommend that systolic blood pressure (SBP) in patients with heart failure with preserved ejection fraction (HFpEF) and hypertension be lowered to <130 mm Hg.
Of the 6778 hospitalized patients with HFpEF and a history of hypertension in the Medicare-linked OPTIMIZE-HF registry, 3111 had a discharge SBP <130 mm Hg. Using propensity scores for SBP <130 mm Hg, we assembled a matched cohort of 1979 pairs with SBP <130 versus ≥130 mm Hg, balanced on 66 baseline characteristics (mean age, 79 years; 69% women; 12% African American). We then assembled a second matched cohort of 1326 pairs with SBP <120 versus ≥130 mm Hg. Hazard ratios (HRs) and 95% confidence intervals (CIs) for outcomes associated with SBP <130 and <120 mm Hg were separately estimated in the matched cohorts using SBP ≥130 mm Hg as the reference.
HRs (95% CIs) for 30-day, 12-month, and 6-year all-cause mortality associated with SBP <130 mm Hg were 1.20 (0.91-1.59; P = 0.200), 1.11 (0.99-1.26; P = 0.080), and 1.05 (0.98-1.14; P = 0.186), respectively. Respective HRs (95% CIs) associated with SBP <120 mm Hg were 1.68 (1.21-2.34; P = 0.002), 1.28 (1.11-1.48; P = 0.001), and 1.11 (1.02-1.22; P = 0.022). There was no association with readmission.
Among older patients with HFpEF and hypertension, compared with SBP ≥130 mm Hg, the new target SBP <130 mm Hg had no association with outcomes but SBP <120 mm Hg was associated with a higher risk of death but not of readmission. Future prospective studies need to evaluate optimal SBP treatment goals in these patients.
新的高血压和心力衰竭指南建议,射血分数保留的心力衰竭(HFpEF)合并高血压患者的收缩压(SBP)应降至<130mmHg。
在医疗保险相关的 OPTIMIZE-HF 登记处的 6778 例 HFpEF 合并高血压住院患者中,有 3111 例出院时 SBP<130mmHg。我们使用 SBP<130mmHg 的倾向评分,为 SBP<130mmHg 与≥130mmHg 的患者组成了 1979 对匹配队列,在 66 项基线特征(平均年龄 79 岁;69%为女性;12%为非裔美国人)上达到平衡。然后,我们为 SBP<120mmHg 与≥130mmHg 的患者组成了第二个匹配队列,包含 1326 对患者。使用 SBP≥130mmHg 作为参考,分别在匹配队列中估计 SBP<130mmHg 和 SBP<120mmHg 与结局相关的风险比(HRs)和 95%置信区间(CIs)。
与 SBP<130mmHg 相关的 30 天、12 个月和 6 年全因死亡率的 HRs(95%CI)分别为 1.20(0.91-1.59;P=0.200)、1.11(0.99-1.26;P=0.080)和 1.05(0.98-1.14;P=0.186)。与 SBP<120mmHg 相关的 HRs(95%CI)分别为 1.68(1.21-2.34;P=0.002)、1.28(1.11-1.48;P=0.001)和 1.11(1.02-1.22;P=0.022)。与再入院无关联。
在 HFpEF 合并高血压的老年患者中,与 SBP≥130mmHg 相比,新的目标 SBP<130mmHg 与结局无关联,但 SBP<120mmHg 与更高的死亡风险相关,但与再入院无关。未来的前瞻性研究需要评估这些患者的最佳 SBP 治疗目标。